CMR Surgical is rapidly expanding to transform surgery with its Versius surgical robot and powerful data analysis.
The company has robots installed in a wide range of countries throughout Europe and the Middle East and recently signed...
Exec Chat: ‘It’s More Than Just A Robot’: Versius' Maker Drives New Culture Of Accountability In Surgery
CMR Surgical's CMO Speaks On Becoming The Class Act Of Surgical Robotics
Listen to this article
Medtech Insight spoke to Mark Slack, the company’s co-founder, to learn about his vision for transforming surgery, including robotics role in improving surgical training and driving better outcomes for patients.
Keep up with the top medtech business and regulatory news.
More from Robotic Surgery
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.
• By
Tim Schmid, executive VP and worldwide chairman of J&J MedTech, expects Shockwave, acquired in April, and Abiomed, purchased in late 2022, to be “long-term gems” for the company. Cardiovascular is among higher-growth segments where J&J has concentrated investments in recent years, along with robotic surgical systems.
• By
This week, a Delaware court awarded Auris Health shareholders $1bn in a lawsuit against Johnson & Johnson; Abbott recalled some FreeStyle Libre 3 sensors; and McKesson purchased a controlling interest in a Florida cancer care chain.
• By
Announced in conjunction with a $97m Series D financing round, Neptune underscores its gastrointestinal focus and robotics aspirations by spinning out Jupiter Endovascular, which will leverage $21m of the funding to support ongoing development of its Endoportal Control technology.
More from Surgery
• By
Inari Medical is updating use instructions for a clot-removing catheter due to the potential for serious adverse effects, including death.
• By
The Acton, MA-based tubeless insulin pump specialist expands its indication for the Omnipod 5 AID system beyond type 1 diabetes as FDA authorization for type 2 comes sooner than Wall Street expected. Analysts expect clearances of rival systems from Tandem Diabetes Care and Medtronic in 2025, but believe Insulet is well-positioned to compete.
• By
This week, a medical group sued the FDA to block a lab-developed test rule; the FDA published guidance on device classifications; Defibtec issued a recall of its chest compression device and ICU Medical updated instructions for its infusion pump batteries; Maui Imaging raised a $4m DOD grant to put imaging tech into military-based trauma units.